RACGP frustrated on cannabis

cannabis medicinal
The RACGP has called for an end to what it calls “the highly bureaucratic, time-consuming and expensive process for prescribing medicinal cannabis products” RACGP President Dr Bastian Seidel says a consistent national regulatory framework for prescribing medicinal cannabis products would help ensure patient welfare is at the centre of this difficult and rapidly evolving area

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous EpiPen supply returning to normal
Next Prices to nosedive